Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer

Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer

Significant ethnic differences in susceptibility to the effects of chemotherapy exist. Here, we retrospectively analyzed the safety and efficacy of induction chemotherapy (ICT) with dose-modified docetaxel, cisplatin, and 5-fluorouracil (TPF) in Asian patients with borderline resectable or unresecta...

Full description

Bibliographic Details
Main Authors: Hung-Ming Wang, Chien-Yu Lin, Chia-Hsun Hsieh, Cheng-Lung Hsu, Kang-Hsing Fan, Joseph Tung-Chieh Chang, Shiang-Fu Huang, Chung-Jan Kang, Chun-Ta Liao, Shu-Hang Ng, Tzu-Chen Yen
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:Journal of the Formosan Medical Association
Subjects:
Asia
docetaxel
head and neck cancer
induction chemotherapy
resectability
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664616300158

Internet

http://www.sciencedirect.com/science/article/pii/S0929664616300158

Similar Items